{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T19:38:45Z","timestamp":1790019525579,"version":"4.0.1"},"reference-count":193,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"vor","delay-in-days":51,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100006244","name":"Stichting Kinderen Kankervrij","doi-asserted-by":"publisher","award":["329"],"award-info":[{"award-number":["329"]}],"id":[{"id":"10.13039\/501100006244","id-type":"DOI","asserted-by":"publisher"}]},{"name":"EuCanKids"},{"name":"Health Holland","award":["HH-PPS-24061-PC-H027"],"award-info":[{"award-number":["HH-PPS-24061-PC-H027"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-026-04423-0","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T05:38:35Z","timestamp":1777268315000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Lipid nanoparticles for bone marrow-targeted RNA therapeutics"],"prefix":"10.1186","volume":"24","author":[{"given":"L. D. Mata","family":"Casimiro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Escudero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"du Plessis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Schiffelers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Heidenreich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,27]]},"reference":[{"issue":"8","key":"4423_CR1","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1038\/s41409-022-01691-w","volume":"57","author":"JA Snowden","year":"2022","unstructured":"Snowden JA, S\u00e1nchez-Ortega I, Corbacioglu S, Basak GW, Chabannon C, De La Camara R, et al. Indications for haematopoietic cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2022. Bone Marrow Transplant. 2022;57(8):1217\u201339. https:\/\/doi.org\/10.1038\/s41409-022-01691-w.","journal-title":"Bone Marrow Transplant"},{"issue":"6465","key":"4423_CR2","doi-asserted-by":"publisher","DOI":"10.1126\/science.aan4673","volume":"366","author":"S Jaiswal","year":"2019","unstructured":"Jaiswal S, Ebert BL. Clonal hematopoiesis in human aging and disease. Science. 2019;366(6465):eaan4673. https:\/\/doi.org\/10.1126\/science.aan4673.","journal-title":"Science"},{"issue":"10","key":"4423_CR3","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.1038\/s41409-021-01328-4","volume":"56","author":"A Esquirol","year":"2021","unstructured":"Esquirol A, Pascual MJ, Kwon M, P\u00e9rez A, Parody R, Ferra C, et al. Severe infections and infection-related mortality in a large series of haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide. Bone Marrow Transplant. 2021;56(10):2432\u201344. https:\/\/doi.org\/10.1038\/s41409-021-01328-4.","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"4423_CR4","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/bjh.14475","volume":"177","author":"RJ Orlowski","year":"2017","unstructured":"Orlowski RJ, Porter DL, Frey NV. The promise of chimeric antigen receptor T cells (CARTs) in leukaemia. Br J Haematol. 2017;177(1):13\u201326. https:\/\/doi.org\/10.1111\/bjh.14475.","journal-title":"Br J Haematol"},{"issue":"5","key":"4423_CR5","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3324\/haematol.2021.279189","volume":"107","author":"D Niederwieser","year":"2022","unstructured":"Niederwieser D, Baldomero H, Bazuaye N, Bupp C, Chaudhri N, Corbacioglu S, et al. One and a half million hematopoietic stem cell transplants: continuous and differential improvement in worldwide access with the use of non-identical family donors. Haematologica. 2022;107(5):5. https:\/\/doi.org\/10.3324\/haematol.2021.279189.","journal-title":"Haematologica"},{"key":"4423_CR6","doi-asserted-by":"publisher","DOI":"10.1200\/EDBK_397912","volume":"43","author":"ERS Cliff","year":"2023","unstructured":"Cliff ERS, Kelkar AH, Russler-Germain DA, Tessema FA, Raymakers AJN, Feldman WB, et al. High Cost of Chimeric Antigen Receptor T-Cells: Challenges and Solutions. Am Soc Clin Oncol Educ Book. 2023;43:e397912. https:\/\/doi.org\/10.1200\/EDBK_397912.","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"1","key":"4423_CR7","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.molcel.2021.11.026","volume":"82","author":"H Iwakawa","year":"2022","unstructured":"Iwakawa H, Tomari Y. Life of RISC: formation, action, and degradation of RNA-induced silencing complex. Mol Cell. 2022;82(1):30\u201343. https:\/\/doi.org\/10.1016\/j.molcel.2021.11.026.","journal-title":"Mol Cell"},{"issue":"6","key":"4423_CR8","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.1016\/j.ymthe.2025.03.034","volume":"33","author":"MM \u017bak","year":"2025","unstructured":"\u017bak MM, Zangi L. Clinical development of therapeutic mRNA applications. Mol Ther. 2025;33(6):2583\u2013609. https:\/\/doi.org\/10.1016\/j.ymthe.2025.03.034.","journal-title":"Mol Ther"},{"issue":"7785","key":"4423_CR9","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/s41586-019-1711-4","volume":"576","author":"AV Anzalone","year":"2019","unstructured":"Anzalone AV, Randolph PB, Davis JR, Sousa AA, Koblan LW, Levy JM, et al. Search-and-replace genome editing without double-strand breaks or donor DNA. Nature. 2019;576(7785):149\u201357. https:\/\/doi.org\/10.1038\/s41586-019-1711-4.","journal-title":"Nature"},{"issue":"12","key":"4423_CR10","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/s41576-018-0059-1","volume":"19","author":"HA Rees","year":"2018","unstructured":"Rees HA, Liu DR. Base editing: precision chemistry on the genome and transcriptome of living cells. Nat Rev Genet. 2018;19(12):770\u201388. https:\/\/doi.org\/10.1038\/s41576-018-0059-1.","journal-title":"Nat Rev Genet"},{"issue":"9","key":"4423_CR11","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1038\/nbt.3330","volume":"33","author":"E Blanco","year":"2015","unstructured":"Blanco E, Shen H, Ferrari M. Principles of nanoparticle design for overcoming biological barriers to drug delivery. Nat Biotechnol. 2015;33(9):941\u201351. https:\/\/doi.org\/10.1038\/nbt.3330.","journal-title":"Nat Biotechnol"},{"issue":"4","key":"4423_CR12","doi-asserted-by":"publisher","first-page":"3754","DOI":"10.1021\/acsnano.8b07858","volume":"13","author":"J Buck","year":"2019","unstructured":"Buck J, Grossen P, Cullis PR, Huwyler J, Witzigmann D. Lipid-based DNA therapeutics: hallmarks of non-viral gene delivery. ACS Nano. 2019;13(4):3754\u201382. https:\/\/doi.org\/10.1021\/acsnano.8b07858.","journal-title":"ACS Nano"},{"issue":"9","key":"4423_CR13","doi-asserted-by":"publisher","first-page":"1700375","DOI":"10.1002\/smtd.201700375","volume":"2","author":"MJW Evers","year":"2018","unstructured":"Evers MJW, Kulkarni JA, Van Der Meel R, Cullis PR, Vader P, Schiffelers RM. State-of-the-Art Design and Rapid-Mixing Production Techniques of Lipid Nanoparticles for Nucleic Acid Delivery. Small Methods. 2018;2(9):1700375. https:\/\/doi.org\/10.1002\/smtd.201700375.","journal-title":"Small Methods"},{"key":"4423_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2022.114416","volume":"188","author":"C Hald Albertsen","year":"2022","unstructured":"Hald Albertsen C, Kulkarni JA, Witzigmann D, Lind M, Petersson K, Simonsen JB. The role of lipid components in lipid nanoparticles for vaccines and gene therapy. Adv Drug Deliv Rev. 2022;188:114416. https:\/\/doi.org\/10.1016\/j.addr.2022.114416.","journal-title":"Adv Drug Deliv Rev"},{"issue":"5","key":"4423_CR15","doi-asserted-by":"publisher","first-page":"4787","DOI":"10.1021\/acsnano.8b01516","volume":"12","author":"JA Kulkarni","year":"2018","unstructured":"Kulkarni JA, Darjuan MM, Mercer JE, Chen S, van der Meel R, Thewalt JL, et al. On the Formation and Morphology of Lipid Nanoparticles Containing Ionizable Cationic Lipids and siRNA. ACS Nano. 2018;12(5):4787\u201395. https:\/\/doi.org\/10.1021\/acsnano.8b01516.","journal-title":"ACS Nano"},{"issue":"34","key":"4423_CR16","doi-asserted-by":"publisher","first-page":"18440","DOI":"10.1021\/jp303267y","volume":"116","author":"AKK Leung","year":"2012","unstructured":"Leung AKK, Hafez IM, Baoukina S, Belliveau NM, Zhigaltsev IV, Afshinmanesh E, et al. Lipid Nanoparticles Containing siRNA Synthesized by Microfluidic Mixing Exhibit an Electron-Dense Nanostructured Core. J Phys Chem C. 2012;116(34):18440\u201350. https:\/\/doi.org\/10.1021\/jp303267y.","journal-title":"J Phys Chem C"},{"key":"4423_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2022.114416","volume":"188","author":"C Hald Albertsen","year":"2022","unstructured":"Hald Albertsen C, Kulkarni JA, Witzigmann D, Lind M, Petersson K, Simonsen JB. The role of lipid components in lipid nanoparticles for vaccines and gene therapy. Adv Drug Deliv Rev. 2022;188:114416. https:\/\/doi.org\/10.1016\/j.addr.2022.114416.","journal-title":"Adv Drug Deliv Rev"},{"key":"4423_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41565-024-01833-9","author":"M O\u2019Brien Laramy","year":"2025","unstructured":"O\u2019Brien Laramy M, Foley DA, Pak RH, Lewis JA, McKinney E, Egan PM, et al. Chemistry, manufacturing and controls strategies for using novel excipients in lipid nanoparticles. Nat Nanotechnol. 2025. https:\/\/doi.org\/10.1038\/s41565-024-01833-9.","journal-title":"Nat Nanotechnol"},{"issue":"37","key":"4423_CR19","doi-asserted-by":"publisher","first-page":"2203669","DOI":"10.1002\/adfm.202203669","volume":"32","author":"AR Ferhan","year":"2022","unstructured":"Ferhan AR, Park S, Park H, Tae H, Jackman JA, Cho N. Lipid Nanoparticle Technologies for Nucleic Acid Delivery: A Nanoarchitectonics Perspective. Adv Funct Mater. 2022;32(37):2203669. https:\/\/doi.org\/10.1002\/adfm.202203669.","journal-title":"Adv Funct Mater"},{"key":"4423_CR20","unstructured":"Endosomal escape: A bottleneck for LNP-mediated therapeutics [Internet]. [cited 2025 Feb 21]. Available from: https:\/\/www.pnas.org\/doi\/epub\/10.1073\/pnas.2307800120"},{"key":"4423_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/mtna.2013.66","volume":"2","author":"BL Mui","year":"2013","unstructured":"Mui BL, Tam YK, Jayaraman M, Ansell SM, Du X, Tam YYC, et al. Influence of Polyethylene Glycol Lipid Desorption Rates on Pharmacokinetics and Pharmacodynamics of siRNA Lipid Nanoparticles. Mol Ther - Nucleic Acids. 2013;2:e139. https:\/\/doi.org\/10.1038\/mtna.2013.66.","journal-title":"Mol Ther - Nucleic Acids"},{"key":"4423_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtadv.2022.100299","volume":"16","author":"I Menon","year":"2022","unstructured":"Menon I, Zaroudi M, Zhang Y, Aisenbrey E, Hui L. Fabrication of active targeting lipid nanoparticles: Challenges and perspectives. Mater Today Adv. 2022;16:100299. https:\/\/doi.org\/10.1016\/j.mtadv.2022.100299.","journal-title":"Mater Today Adv"},{"key":"4423_CR23","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.jconrel.2024.10.014","volume":"376","author":"D Tarab-Ravski","year":"2024","unstructured":"Tarab-Ravski D, Stotsky-Oterin L, Elisha A, Kundoor GR, Ramishetti S, Hazan-Halevy I, et al. The future of genetic medicines delivered via targeted lipid nanoparticles to leukocytes. J Controlled Release. 2024;376:286\u2013302. https:\/\/doi.org\/10.1016\/j.jconrel.2024.10.014.","journal-title":"J Controlled Release"},{"issue":"12","key":"4423_CR24","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1038\/s41565-019-0591-y","volume":"14","author":"A Akinc","year":"2019","unstructured":"Akinc A, Maier MA, Manoharan M, Fitzgerald K, Jayaraman M, Barros S, et al. The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs. Nat Nanotechnol. 2019;14(12):1084\u20137. https:\/\/doi.org\/10.1038\/s41565-019-0591-y.","journal-title":"Nat Nanotechnol"},{"key":"4423_CR25","unstructured":"FDA C for BE and. MRESVIA. FDA [Internet]. 2024 Jun 27 [cited 2024 Aug 27]. Available from: https:\/\/www.fda.gov\/vaccines-blood-biologics\/vaccines\/mresvia"},{"issue":"4","key":"4423_CR26","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1007\/s13346-021-00911-y","volume":"11","author":"L Milane","year":"2021","unstructured":"Milane L, Amiji M. Clinical approval of nanotechnology-based SARS-CoV-2 mRNA vaccines: impact on translational nanomedicine. Drug Deliv Transl Res. 2021;11(4):1309\u201315. https:\/\/doi.org\/10.1007\/s13346-021-00911-y.","journal-title":"Drug Deliv Transl Res"},{"issue":"1","key":"4423_CR27","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-019-2745-x","volume":"37","author":"A Al Shoyaib","year":"2019","unstructured":"Al Shoyaib A, Archie SR, Karamyan VT. Intraperitoneal route of drug administration: should it be used in experimental animal studies? Pharm Res. 2019;37(1):12. https:\/\/doi.org\/10.1007\/s11095-019-2745-x.","journal-title":"Pharm Res"},{"issue":"1","key":"4423_CR28","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s11095-022-03166-5","volume":"39","author":"J Di","year":"2022","unstructured":"Di J, Du Z, Wu K, Jin S, Wang X, Li T, et al. Biodistribution and non-linear gene expression of mRNA LNPs affected by delivery route and particle size. Pharm Res. 2022;39(1):105\u201314. https:\/\/doi.org\/10.1007\/s11095-022-03166-5.","journal-title":"Pharm Res"},{"key":"4423_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.nantod.2024.102325","volume":"57","author":"R Ma","year":"2024","unstructured":"Ma R, Li Y, Wei Y, Zhou J, Ma J, Zhang M, et al. The dynamic process of mRNA delivery by lipid nanoparticles in vivo. Nano Today. 2024;57:102325. https:\/\/doi.org\/10.1016\/j.nantod.2024.102325.","journal-title":"Nano Today"},{"issue":"9","key":"4423_CR30","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1021\/acs.bioconjchem.0c00366","volume":"31","author":"V Francia","year":"2020","unstructured":"Francia V, Schiffelers RM, Cullis PR, Witzigmann D. The biomolecular corona of lipid nanoparticles for gene therapy. Bioconjug Chem. 2020;31(9):2046\u201359. https:\/\/doi.org\/10.1021\/acs.bioconjchem.0c00366.","journal-title":"Bioconjug Chem"},{"key":"4423_CR31","doi-asserted-by":"publisher","DOI":"10.1002\/smsc.202500206","author":"A Greco","year":"2025","unstructured":"Greco A, Corbo C. Therapeutic implications of biomolecular corona on lipid nanoparticle\u2010based gene delivery systems. Small Sci. 2025. https:\/\/doi.org\/10.1002\/smsc.202500206.","journal-title":"Small Sci"},{"issue":"3","key":"4423_CR32","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1021\/acsnano.6b06245","volume":"11","author":"SA MacParland","year":"2017","unstructured":"MacParland SA, Tsoi KM, Ouyang B, Ma XZ, Manuel J, Fawaz A, et al. Phenotype determines nanoparticle uptake by human macrophages from liver and blood. ACS Nano. 2017;11(3):2428\u201343. https:\/\/doi.org\/10.1021\/acsnano.6b06245.","journal-title":"ACS Nano"},{"issue":"3","key":"4423_CR33","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1021\/nn2000756","volume":"5","author":"O Lunov","year":"2011","unstructured":"Lunov O, Syrovets T, Loos C, Beil J, Delacher M, Tron K, et al. Differential uptake of functionalized polystyrene nanoparticles by human macrophages and a monocytic cell line. ACS Nano. 2011;5(3):1657\u201369. https:\/\/doi.org\/10.1021\/nn2000756.","journal-title":"ACS Nano"},{"issue":"1","key":"4423_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-39768-9","volume":"14","author":"K Liu","year":"2023","unstructured":"Liu K, Nilsson R, L\u00e1zaro-Ib\u00e1\u00f1ez E, Du\u00e0n H, Miliotis T, Strimfors M, et al. Multiomics analysis of naturally efficacious lipid nanoparticle coronas reveals high-density lipoprotein is necessary for their function. Nat Commun. 2023;14(1):4007. https:\/\/doi.org\/10.1038\/s41467-023-39768-9.","journal-title":"Nat Commun"},{"key":"4423_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41565-024-01680-8","author":"X Lian","year":"2024","unstructured":"Lian X, Chatterjee S, Sun Y, Dilliard SA, Moore S, Xiao Y, et al. Bone-marrow-homing lipid nanoparticles for genome editing in diseased and malignant haematopoietic stem cells. Nat Nanotechnol. 2024. https:\/\/doi.org\/10.1038\/s41565-024-01680-8.","journal-title":"Nat Nanotechnol"},{"issue":"4","key":"4423_CR36","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1038\/s41565-024-01847-3","volume":"20","author":"SRJ Hofstraat","year":"2025","unstructured":"Hofstraat SRJ, Anbergen T, Zwolsman R, Deckers J, Van Elsas Y, Trines MM, et al. Nature-inspired platform nanotechnology for RNA delivery to myeloid cells and their bone marrow progenitors. Nat Nanotechnol. 2025;20(4):532\u201342. https:\/\/doi.org\/10.1038\/s41565-024-01847-3.","journal-title":"Nat Nanotechnol"},{"issue":"235","key":"4423_CR37","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.jconrel.2016.05.059","volume":"10","author":"S Chen","year":"2016","unstructured":"Chen S, Tam YYC, Lin PJC, Sung MMH, Tam YK, Cullis PR. Influence of particle size on the in vivo potency of lipid nanoparticle formulations of siRNA. J Controlled Release. 2016;10(235):236\u201344. https:\/\/doi.org\/10.1016\/j.jconrel.2016.05.059.","journal-title":"J Controlled Release"},{"issue":"17","key":"4423_CR38","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1038\/gt.2008.60","volume":"15","author":"E Wisse","year":"2008","unstructured":"Wisse E, Jacobs F, Topal B, Frederik P, De Geest B. The size of endothelial fenestrae in human liver sinusoids: implications for hepatocyte-directed gene transfer. Gene Ther. 2008;15(17):1193\u20139. https:\/\/doi.org\/10.1038\/gt.2008.60.","journal-title":"Gene Ther"},{"key":"4423_CR39","doi-asserted-by":"crossref","unstructured":"Cogger VC, Hunt NJ, Le Couteur DG. Fenestrations in the Liver Sinusoidal Endothelial Cell. In: Arias IM, Alter HJ, Boyer JL, Cohen DE, Shafritz DA, Thorgeirsson SS, et al., editors. The Liver [Internet]. 1st ed. Wiley; 2020 [cited 2024 Oct 31]. p. 435\u201343. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/9781119436812.ch35","DOI":"10.1002\/9781119436812.ch35"},{"issue":"21","key":"4423_CR40","doi-asserted-by":"publisher","first-page":"R1147","DOI":"10.1016\/j.cub.2017.09.019","volume":"27","author":"E Trefts","year":"2017","unstructured":"Trefts E, Gannon M, Wasserman DH. The liver. Curr Biol. 2017;27(21):R1147\u201351. https:\/\/doi.org\/10.1016\/j.cub.2017.09.019.","journal-title":"Curr Biol"},{"issue":"5","key":"4423_CR41","doi-asserted-by":"publisher","first-page":"5785","DOI":"10.1021\/acsnano.9b01383","volume":"13","author":"W Poon","year":"2019","unstructured":"Poon W, Zhang YN, Ouyang B, Kingston BR, Wu JLY, Wilhelm S, et al. Elimination Pathways of Nanoparticles. ACS Nano. 2019;13(5):5785\u201398. https:\/\/doi.org\/10.1021\/acsnano.9b01383.","journal-title":"ACS Nano"},{"issue":"21","key":"4423_CR42","doi-asserted-by":"publisher","first-page":"10661","DOI":"10.1021\/acs.analchem.6b03109","volume":"88","author":"BM Chen","year":"2016","unstructured":"Chen BM, Su YC, Chang CJ, Burnouf PA, Chuang KH, Chen CH, et al. Measurement of Pre-Existing IgG and IgM Antibodies against Polyethylene Glycol in Healthy Individuals. Anal Chem. 2016;88(21):10661\u20136. https:\/\/doi.org\/10.1021\/acs.analchem.6b03109.","journal-title":"Anal Chem"},{"issue":"23","key":"4423_CR43","doi-asserted-by":"publisher","first-page":"11804","DOI":"10.1021\/acs.analchem.6b03437","volume":"88","author":"Q Yang","year":"2016","unstructured":"Yang Q, Jacobs TM, McCallen JD, Moore DT, Huckaby JT, Edelstein JN, et al. Analysis of Pre-existing IgG and IgM Antibodies against Polyethylene Glycol (PEG) in the General Population. Anal Chem. 2016;88(23):11804\u201312. https:\/\/doi.org\/10.1021\/acs.analchem.6b03437.","journal-title":"Anal Chem"},{"key":"4423_CR44","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.jconrel.2021.11.042","volume":"341","author":"M Estap\u00e9 Senti","year":"2022","unstructured":"Estap\u00e9 Senti M, De Jongh CA, Dijkxhoorn K, Verhoef JJF, Szebeni J, Storm G, et al. Anti-PEG antibodies compromise the integrity of PEGylated lipid-based nanoparticles via complement. J Controlled Release. 2022;341:475\u201386. https:\/\/doi.org\/10.1016\/j.jconrel.2021.11.042.","journal-title":"J Controlled Release"},{"key":"4423_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2020.119792","volume":"588","author":"T Suzuki","year":"2020","unstructured":"Suzuki T, Suzuki Y, Hihara T, Kubara K, Kondo K, Hyodo K, et al. PEG shedding-rate-dependent blood clearance of PEGylated lipid nanoparticles in mice: Faster PEG shedding attenuates anti-PEG IgM production. Int J Pharm. 2020;588:119792. https:\/\/doi.org\/10.1016\/j.ijpharm.2020.119792.","journal-title":"Int J Pharm"},{"key":"4423_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2021.114079","volume":"180","author":"D Shi","year":"2022","unstructured":"Shi D, Beasock D, Fessler A, Szebeni J, Ljubimova JY, Afonin KA, et al. To PEGylate or not to PEGylate: immunological properties of nanomedicine\u2019s most popular component, polyethylene glycol and its alternatives. Adv Drug Deliv Rev. 2022;180:114079. https:\/\/doi.org\/10.1016\/j.addr.2021.114079.","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"4423_CR47","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jconrel.2006.01.005","volume":"112","author":"T Ishida","year":"2006","unstructured":"Ishida T, Ichihara M, Wang X, Yamamoto K, Kimura J, Majima E, et al. Injection of PEGylated liposomes in rats elicits PEG-specific IgM, which is responsible for rapid elimination of a second dose of PEGylated liposomes. J Control Release. 2006;112(1):15\u201325. https:\/\/doi.org\/10.1016\/j.jconrel.2006.01.005.","journal-title":"J Control Release"},{"key":"4423_CR48","unstructured":"Development of Lipid Nanoparticle Formulation for the Repeated Administration of mRNA Therapeutics [Internet]. [cited 2024 Oct 29]. Available from: https:\/\/spj.science.org\/doi\/10.34133\/bmr.0017"},{"issue":"2","key":"4423_CR49","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.molimm.2014.06.038","volume":"61","author":"J Szebeni","year":"2014","unstructured":"Szebeni J. Complement activation-related pseudoallergy: a stress reaction in blood triggered by nanomedicines and biologicals. Mol Immunol. 2014;61(2):163\u201373. https:\/\/doi.org\/10.1016\/j.molimm.2014.06.038.","journal-title":"Mol Immunol"},{"issue":"4","key":"4423_CR50","doi-asserted-by":"publisher","first-page":"6709","DOI":"10.1021\/acsnano.0c10064","volume":"15","author":"F Sebastiani","year":"2021","unstructured":"Sebastiani F, Yanez Arteta M, Lerche M, Porcar L, Lang C, Bragg RA, et al. Apolipoprotein E binding drives structural and compositional rearrangement of mRNA-containing lipid nanoparticles. ACS Nano. 2021;15(4):6709\u201322. https:\/\/doi.org\/10.1021\/acsnano.0c10064.","journal-title":"ACS Nano"},{"issue":"2","key":"4423_CR51","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1021\/mp500400k","volume":"12","author":"SC Wilson","year":"2015","unstructured":"Wilson SC, Baryza JL, Reynolds AJ, Bowman K, Keegan ME, Standley SM, et al. Real time measurement of PEG shedding from lipid nanoparticles in serum via NMR spectroscopy. Mol Pharm. 2015;12(2):386\u201392. https:\/\/doi.org\/10.1021\/mp500400k.","journal-title":"Mol Pharm"},{"key":"4423_CR52","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.addr.2019.08.004","volume":"144","author":"S Patel","year":"2019","unstructured":"Patel S, Kim J, Herrera M, Mukherjee A, Kabanov AV, Sahay G. Brief update on endocytosis of nanomedicines. Adv Drug Deliv Rev. 2019;144:90\u2013111. https:\/\/doi.org\/10.1016\/j.addr.2019.08.004.","journal-title":"Adv Drug Deliv Rev"},{"issue":"15","key":"4423_CR53","doi-asserted-by":"publisher","first-page":"2806","DOI":"10.1016\/j.cell.2022.03.045","volume":"185","author":"A Raguram","year":"2022","unstructured":"Raguram A, Banskota S, Liu DR. Therapeutic in vivo delivery of gene editing agents. Cell. 2022;185(15):2806\u201327. https:\/\/doi.org\/10.1016\/j.cell.2022.03.045.","journal-title":"Cell"},{"issue":"7","key":"4423_CR54","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/nbt.2612","volume":"31","author":"J Gilleron","year":"2013","unstructured":"Gilleron J, Querbes W, Zeigerer A, Borodovsky A, Marsico G, Schubert U, et al. Image-based analysis of lipid nanoparticle\u2013mediated siRNA delivery, intracellular trafficking and endosomal escape. Nat Biotechnol. 2013;31(7):638\u201346. https:\/\/doi.org\/10.1038\/nbt.2612.","journal-title":"Nat Biotechnol"},{"issue":"17","key":"4423_CR55","doi-asserted-by":"publisher","first-page":"3481","DOI":"10.1038\/emboj.2011.286","volume":"30","author":"J Huotari","year":"2011","unstructured":"Huotari J, Helenius A. Endosome maturation: endosome maturation. EMBO J. 2011;30(17):3481\u2013500. https:\/\/doi.org\/10.1038\/emboj.2011.286.","journal-title":"EMBO J"},{"key":"4423_CR56","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.omtm.2023.06.005","volume":"30","author":"N Chander","year":"2023","unstructured":"Chander N, Basha G, Yan Cheng MH, Witzigmann D, Cullis PR. Lipid nanoparticle mRNA systems containing high levels of sphingomyelin engender higher protein expression in hepatic and extra-hepatic tissues. Mol Ther Methods Clin Dev. 2023;30:235\u201345. https:\/\/doi.org\/10.1016\/j.omtm.2023.06.005.","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"21","key":"4423_CR57","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202301377","volume":"10","author":"D Tarab-Ravski","year":"2023","unstructured":"Tarab-Ravski D, Hazan-Halevy I, Goldsmith M, Stotsky-Oterin L, Breier D, Naidu GS, et al. Delivery of therapeutic RNA to the bone marrow in Multiple Myeloma using CD38-targeted lipid nanoparticles. Adv Sci. 2023;10(21):2301377. https:\/\/doi.org\/10.1002\/advs.202301377.","journal-title":"Adv Sci"},{"issue":"11","key":"4423_CR58","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1038\/s41587-024-02470-2","volume":"43","author":"H Kim","year":"2025","unstructured":"Kim H, Zenhausern R, Gentry K, et al. Lipid nanoparticle-mediated mRNA delivery to CD34+ cells in rhesus monkeys. Nature Biotechnology. 2025;43(11):1813\u201320. https:\/\/doi.org\/10.1038\/s41587-024-02470-2.","journal-title":"Nature biotechnology."},{"issue":"1","key":"4423_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14527-2","volume":"11","author":"S Patel","year":"2020","unstructured":"Patel S, Ashwanikumar N, Robinson E, Xia Y, Mihai C, Griffith JP, et al. Naturally-occurring cholesterol analogues in lipid nanoparticles induce polymorphic shape and enhance intracellular delivery of mRNA. Nat Commun. 2020;11(1):983. https:\/\/doi.org\/10.1038\/s41467-020-14527-2.","journal-title":"Nat Commun"},{"issue":"1","key":"4423_CR60","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15300-1","volume":"11","author":"H Du Rietz","year":"2020","unstructured":"Du Rietz H, Hedlund H, Wilhelmson S, Nordenfelt P, Wittrup A. Imaging small molecule-induced endosomal escape of siRNA. Nat Commun. 2020;11(1):1809. https:\/\/doi.org\/10.1038\/s41467-020-15300-1.","journal-title":"Nat Commun"},{"key":"4423_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2023.115047","volume":"200","author":"A Klipp","year":"2023","unstructured":"Klipp A, Burger M, Leroux JC. Get out or die trying: peptide- and protein-based endosomal escape of RNA therapeutics. Adv Drug Deliv Rev. 2023;200:115047. https:\/\/doi.org\/10.1016\/j.addr.2023.115047.","journal-title":"Adv Drug Deliv Rev"},{"issue":"5","key":"4423_CR62","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1080\/01926230600939856","volume":"34","author":"GS Travlos","year":"2006","unstructured":"Travlos GS. Normal structure, function, and histology of the bone marrow. Toxicol Pathol. 2006;34(5):548\u201365. https:\/\/doi.org\/10.1080\/01926230600939856.","journal-title":"Toxicol Pathol"},{"issue":"12","key":"4423_CR63","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1007\/s10439-008-9577-x","volume":"36","author":"UA Gurkan","year":"2008","unstructured":"Gurkan UA, Akkus O. The mechanical environment of bone marrow: a review. Ann Biomed Eng. 2008;36(12):1978\u201391. https:\/\/doi.org\/10.1007\/s10439-008-9577-x.","journal-title":"Ann Biomed Eng"},{"key":"4423_CR64","doi-asserted-by":"publisher","unstructured":"Boes KM, Durham AC. Bone Marrow, Blood Cells, and the Lymphoid\/Lymphatic System. Pathol Basis Vet Dis. 2017;724\u2013804.e2. https:\/\/doi.org\/10.1016\/B978-0-323-35775-3.00013-8","DOI":"10.1016\/B978-0-323-35775-3.00013-8"},{"issue":"4","key":"4423_CR65","doi-asserted-by":"publisher","first-page":"45","DOI":"10.12659\/PJR.883628","volume":"77","author":"A Ma\u0142kiewicz","year":"2012","unstructured":"Ma\u0142kiewicz A, Dziedzic M. Bone marrow reconversion \u2013 imaging of physiological changes in bone marrow. Pol J Radiol. 2012;77(4):45\u201350.","journal-title":"Pol J Radiol"},{"issue":"2","key":"4423_CR66","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.stemcr.2020.06.011","volume":"15","author":"AG Aguilar-Navarro","year":"2020","unstructured":"Aguilar-Navarro AG, Meza-Le\u00f3n B, Gratzinger D, Ju\u00e1rez-Aguilar FG, Chang Q, Ornatsky O, et al. Human aging alters the spatial organization between CD34+ hematopoietic cells and adipocytes in bone marrow. Stem Cell Reports. 2020;15(2):317\u201325. https:\/\/doi.org\/10.1016\/j.stemcr.2020.06.011.","journal-title":"Stem Cell Reports"},{"issue":"1","key":"4423_CR67","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1097\/MOH.0000000000000621","volume":"28","author":"D Lucas","year":"2021","unstructured":"Lucas D. Structural organization of the bone marrow and its role in hematopoiesis. Curr Opin Hematol. 2021;28(1):36\u201342. https:\/\/doi.org\/10.1097\/MOH.0000000000000621.","journal-title":"Curr Opin Hematol"},{"issue":"6","key":"4423_CR68","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1182\/bloodadvances.2016003194","volume":"1","author":"C Nombela-Arrieta","year":"2017","unstructured":"Nombela-Arrieta C, Manz MG. Quantification and three-dimensional microanatomical organization of the bone marrow. Blood Adv. 2017;1(6):407\u201316. https:\/\/doi.org\/10.1182\/bloodadvances.2016003194.","journal-title":"Blood Adv"},{"issue":"7492","key":"4423_CR69","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/nature13145","volume":"507","author":"AP Kusumbe","year":"2014","unstructured":"Kusumbe AP, Ramasamy SK, Adams RH. Coupling of angiogenesis and osteogenesis by a specific vessel subtype in bone. Nature. 2014;507(7492):323\u20138. https:\/\/doi.org\/10.1038\/nature13145.","journal-title":"Nature"},{"issue":"7599","key":"4423_CR70","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/nature17624","volume":"532","author":"T Itkin","year":"2016","unstructured":"Itkin T, Gur-Cohen S, Spencer JA, Schajnovitz A, Ramasamy SK, Kusumbe AP, et al. Distinct bone marrow blood vessels differentially regulate haematopoiesis. Nature. 2016;532(7599):323\u20138. https:\/\/doi.org\/10.1038\/nature17624.","journal-title":"Nature"},{"key":"4423_CR71","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.critrevonc.2019.01.024","volume":"137","author":"M Hassanshahi","year":"2019","unstructured":"Hassanshahi M, Hassanshahi A, Khabbazi S, Su YW, Xian CJ. Bone marrow sinusoidal endothelium as a facilitator\/regulator of cell egress from the bone marrow. Crit Rev Oncol Hematol. 2019;137:43\u201356. https:\/\/doi.org\/10.1016\/j.critrevonc.2019.01.024.","journal-title":"Crit Rev Oncol Hematol"},{"key":"4423_CR72","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.semcdb.2021.06.025","volume":"123","author":"C Owen-Woods","year":"2022","unstructured":"Owen-Woods C, Kusumbe A. Fundamentals of bone vasculature: specialization, interactions and functions. Semin Cell Dev Biol. 2022;123:36\u201347. https:\/\/doi.org\/10.1016\/j.semcdb.2021.06.025.","journal-title":"Semin Cell Dev Biol"},{"key":"4423_CR73","unstructured":"Organotypic vasculature: From descriptive heterogeneity to functional pathophysiology [Internet]. [cited 2025 May 23]. Available from: https:\/\/www.science.org\/doi\/10.1126\/science.aal2379"},{"issue":"12","key":"4423_CR74","doi-asserted-by":"publisher","first-page":"3120","DOI":"10.1016\/j.cell.2024.04.013","volume":"187","author":"S Bandyopadhyay","year":"2024","unstructured":"Bandyopadhyay S, Duffy MP, Ahn KJ, Sussman JH, Pang M, Smith D, et al. Mapping the cellular biogeography of human bone marrow niches using single-cell transcriptomics and proteomic imaging. Cell. 2024;187(12):3120-3140.e29. https:\/\/doi.org\/10.1016\/j.cell.2024.04.013.","journal-title":"Cell"},{"issue":"7","key":"4423_CR75","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1016\/j.celrep.2017.01.042","volume":"18","author":"MG Bixel","year":"2017","unstructured":"Bixel MG, Kusumbe AP, Ramasamy SK, Sivaraj KK, Butz S, Vestweber D, et al. Flow dynamics and HSPC homing in bone marrow microvessels. Cell Rep. 2017;18(7):1804\u201316. https:\/\/doi.org\/10.1016\/j.celrep.2017.01.042.","journal-title":"Cell Rep"},{"key":"4423_CR76","unstructured":"Imaging the Vascular Bone Marrow Niche During Inflammatory Stress [Internet]. [cited 2025 Feb 7]. Available from: https:\/\/www.ahajournals.org\/doi\/epub\/10.1161\/CIRCRESAHA.118.313302"},{"key":"4423_CR77","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.exphem.2021.07.001","volume":"100","author":"JP L\u00e9vesque","year":"2021","unstructured":"L\u00e9vesque JP, Summers KM, Millard SM, Bisht K, Winkler IG, Pettit AR. Role of macrophages and phagocytes in orchestrating normal and pathologic hematopoietic niches. Exp Hematol. 2021;100:12-31.e1. https:\/\/doi.org\/10.1016\/j.exphem.2021.07.001.","journal-title":"Exp Hematol"},{"issue":"4","key":"4423_CR78","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.7150\/thno.64963","volume":"12","author":"X Zhang","year":"2022","unstructured":"Zhang X, Hou L, Li F, Zhang W, Wu C, Xiang L, et al. Piezo1-mediated mechanosensation in bone marrow macrophages promotes vascular niche regeneration after irradiation injury. Theranostics. 2022;12(4):1621\u201338. https:\/\/doi.org\/10.7150\/thno.64963.","journal-title":"Theranostics"},{"key":"4423_CR79","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2025.113669","volume":"382","author":"JD Martin","year":"2025","unstructured":"Martin JD, Toh K, Martin MR, Chen P, Wang C, Igarashi K, et al. Bone marrow vessels are hyperpermeable to macromolecules and nanoscale medicine in a size-dependent manner. J Control Release. 2025;382:113669. https:\/\/doi.org\/10.1016\/j.jconrel.2025.113669.","journal-title":"J Control Release"},{"issue":"9","key":"4423_CR80","doi-asserted-by":"publisher","first-page":"7098","DOI":"10.1021\/acsnano.3c11201","volume":"18","author":"A Tiwari","year":"2024","unstructured":"Tiwari A, Haj N, Elgrably B, Berihu M, Laskov V, Barash S, et al. Cross-modal imaging reveals nanoparticle uptake dynamics in hematopoietic bone marrow during inflammation. ACS Nano. 2024;18(9):7098\u2013113. https:\/\/doi.org\/10.1021\/acsnano.3c11201.","journal-title":"ACS Nano"},{"key":"4423_CR81","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtm.2024.101314","author":"F Ferraresso","year":"2024","unstructured":"Ferraresso F, Badior K, Seadler M, Zhang Y, Wietrzny A, Cau MF, et al. Protein is expressed in all major organs after intravenous infusion of mRNA-lipid nanoparticles in swine. Mol Ther Methods Clin Dev. 2024. https:\/\/doi.org\/10.1016\/j.omtm.2024.101314.","journal-title":"Mol Ther Methods Clin Dev"},{"key":"4423_CR82","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.00757","volume":"11","author":"X Lin","year":"2020","unstructured":"Lin X, Patil S, Gao YG, Qian A. The bone extracellular matrix in bone formation and regeneration. Front Pharmacol. 2020;11:757. https:\/\/doi.org\/10.3389\/fphar.2020.00757.","journal-title":"Front Pharmacol"},{"key":"4423_CR83","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.exphem.2020.07.010","volume":"89","author":"C Zanetti","year":"2020","unstructured":"Zanetti C, Krause DS. \u201cCaught in the net\u201d: the extracellular matrix of the bone marrow in normal hematopoiesis and leukemia. Exp Hematol. 2020;89:13\u201325. https:\/\/doi.org\/10.1016\/j.exphem.2020.07.010.","journal-title":"Exp Hematol"},{"key":"4423_CR84","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2021.114069","volume":"181","author":"C Lee-Thedieck","year":"2022","unstructured":"Lee-Thedieck C, Schertl P, Klein G. The extracellular matrix of hematopoietic stem cell niches. Adv Drug Deliv Rev. 2022;181:114069. https:\/\/doi.org\/10.1016\/j.addr.2021.114069.","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"4423_CR85","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41413-023-00281-w","volume":"11","author":"M Fontcuberta-Rigo","year":"2023","unstructured":"Fontcuberta-Rigo M, Nakamura M, Puigb\u00f2 P. Phylobone: a comprehensive database of bone extracellular matrix proteins in human and model organisms. Bone Res. 2023;11(1):44. https:\/\/doi.org\/10.1038\/s41413-023-00281-w.","journal-title":"Bone Res"},{"key":"4423_CR86","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.jmbbm.2015.06.023","volume":"50","author":"LE Jansen","year":"2015","unstructured":"Jansen LE, Birch NP, Schiffman JD, Crosby AJ, Peyton SR. Mechanics of intact bone marrow. J Mech Behav Biomed Mater. 2015;50:299\u2013307. https:\/\/doi.org\/10.1016\/j.jmbbm.2015.06.023.","journal-title":"J Mech Behav Biomed Mater"},{"key":"4423_CR87","unstructured":"Davis BL, Praveen SS. NONLINEAR VERSUS LINEAR BEHAVIOR OF CALCANEAL BONE MARROW AT DIFFERENT SHEAR RATES."},{"issue":"26","key":"4423_CR88","doi-asserted-by":"publisher","first-page":"2282","DOI":"10.1182\/blood.2023021280","volume":"142","author":"A Sarachakov","year":"2023","unstructured":"Sarachakov A, Varlamova A, Svekolkin V, Polyakova M, Valencia I, Unkenholz C, et al. Spatial mapping of human hematopoiesis at single-cell resolution reveals aging-associated topographic remodeling. Blood. 2023;142(26):2282\u201395. https:\/\/doi.org\/10.1182\/blood.2023021280.","journal-title":"Blood"},{"issue":"7495","key":"4423_CR89","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/nature13034","volume":"508","author":"JA Spencer","year":"2014","unstructured":"Spencer JA, Ferraro F, Roussakis E, Klein A, Wu J, Runnels JM, et al. Direct measurement of local oxygen concentration in the bone marrow of live animals. Nature. 2014;508(7495):269\u201373. https:\/\/doi.org\/10.1038\/nature13034.","journal-title":"Nature"},{"key":"4423_CR90","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2022.121568","volume":"286","author":"Y Xiao","year":"2022","unstructured":"Xiao Y, McGuinness ChanelleAS, Doherty-Boyd WS, Salmeron-Sanchez M, Donnelly H, Dalby MJ. Current insights into the bone marrow niche: from biology in vivo to bioengineering ex vivo. Biomaterials. 2022;286:121568. https:\/\/doi.org\/10.1016\/j.biomaterials.2022.121568.","journal-title":"Biomaterials"},{"issue":"7308","key":"4423_CR91","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/nature09262","volume":"466","author":"S M\u00e9ndez-Ferrer","year":"2010","unstructured":"M\u00e9ndez-Ferrer S, Michurina TV, Ferraro F, Mazloom AR, MacArthur BD, Lira SA, et al. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature. 2010;466(7308):829\u201334. https:\/\/doi.org\/10.1038\/nature09262.","journal-title":"Nature"},{"issue":"9","key":"4423_CR92","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/nri.2017.53","volume":"17","author":"GM Crane","year":"2017","unstructured":"Crane GM, Jeffery E, Morrison SJ. Adult haematopoietic stem cell niches. Nat Rev Immunol. 2017;17(9):573\u201390. https:\/\/doi.org\/10.1038\/nri.2017.53.","journal-title":"Nat Rev Immunol"},{"issue":"7382","key":"4423_CR93","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/nature10783","volume":"481","author":"L Ding","year":"2012","unstructured":"Ding L, Saunders TL, Enikolopov G, Morrison SJ. Endothelial and perivascular cells maintain haematopoietic stem cells. Nature. 2012;481(7382):457\u201362. https:\/\/doi.org\/10.1038\/nature10783.","journal-title":"Nature"},{"issue":"13","key":"4423_CR94","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1016\/j.devcel.2021.05.018","volume":"56","author":"S Comazzetto","year":"2021","unstructured":"Comazzetto S, Shen B, Morrison SJ. Niches that regulate stem cells and hematopoiesis in adult bone marrow. Dev Cell. 2021;56(13):1848\u201360. https:\/\/doi.org\/10.1016\/j.devcel.2021.05.018.","journal-title":"Dev Cell"},{"issue":"1","key":"4423_CR95","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/s41467-022-27973-x","volume":"13","author":"SCA Yeh","year":"2022","unstructured":"Yeh SCA, Hou J, Wu JW, Yu S, Zhang Y, Belfield KD, et al. Quantification of bone marrow interstitial pH and calcium concentration by intravital ratiometric imaging. Nat Commun. 2022;13(1):393. https:\/\/doi.org\/10.1038\/s41467-022-27973-x.","journal-title":"Nat Commun"},{"issue":"5","key":"4423_CR96","doi-asserted-by":"publisher","DOI":"10.15252\/embr.202255373","volume":"24","author":"S Kumar","year":"2023","unstructured":"Kumar S, Vassallo JD, Nattamai KJ, Hassan A, Karns R, Vollmer A, et al. pH regulates hematopoietic stem cell potential via polyamines. EMBO Rep. 2023;24(5):e55373. https:\/\/doi.org\/10.15252\/embr.202255373.","journal-title":"EMBO Rep"},{"issue":"1","key":"4423_CR97","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/421746","volume":"2015","author":"R Florencio-Silva","year":"2015","unstructured":"Florencio-Silva R, Sasso GRdaS, Sasso-Cerri E, Sim\u00f5es MJ, Cerri PS. Biology of bone tissue: structure, function, and factors that influence bone cells. BioMed Res Int. 2015;2015(1):421746. https:\/\/doi.org\/10.1155\/2015\/421746.","journal-title":"BioMed Res Int"},{"issue":"11","key":"4423_CR98","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1038\/s41580-020-00279-w","volume":"21","author":"A Salhotra","year":"2020","unstructured":"Salhotra A, Shah HN, Levi B, Longaker MT. Mechanisms of bone development and repair. Nat Rev Mol Cell Biol. 2020;21(11):696\u2013711. https:\/\/doi.org\/10.1038\/s41580-020-00279-w.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"4423_CR99","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/bonekey.2013.181","volume":"4","author":"AL Boskey","year":"2013","unstructured":"Boskey AL. Bone composition: relationship to bone fragility and antiosteoporotic drug effects. BoneKEy Rep. 2013;4:2. https:\/\/doi.org\/10.1038\/bonekey.2013.181.","journal-title":"BoneKEy Rep"},{"issue":"5","key":"4423_CR100","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1172\/JCI28568","volume":"116","author":"T Yin","year":"2006","unstructured":"Yin T, Li L. The stem cell niches in bone. J Clin Invest. 2006;116(5):1195\u2013201. https:\/\/doi.org\/10.1172\/JCI28568.","journal-title":"J Clin Invest"},{"issue":"2","key":"4423_CR101","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1111\/ejh.13991","volume":"111","author":"H Li","year":"2023","unstructured":"Li H, Zhou C, Shen Y, Xu M, Wu D, Ye B. Research progress on the hematopoietic microenvironment in aplastic anemia. Eur J Haematol. 2023;111(2):172\u201380. https:\/\/doi.org\/10.1111\/ejh.13991.","journal-title":"Eur J Haematol"},{"issue":"5","key":"4423_CR102","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/s41568-020-0245-2","volume":"20","author":"S M\u00e9ndez-Ferrer","year":"2020","unstructured":"M\u00e9ndez-Ferrer S, Bonnet D, Steensma DP, Hasserjian RP, Ghobrial IM, Gribben JG, et al. Bone marrow niches in haematological malignancies. Nat Rev Cancer. 2020;20(5):285\u201398. https:\/\/doi.org\/10.1038\/s41568-020-0245-2.","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"4423_CR103","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.hoc.2022.12.005","volume":"37","author":"R Bou-Fakhredin","year":"2023","unstructured":"Bou-Fakhredin R, Rivella S, Cappellini MD, Taher AT. Pathogenic mechanisms in Thalassemia I. Hematol Oncol Clin North Am. 2023;37(2):341\u201351. https:\/\/doi.org\/10.1016\/j.hoc.2022.12.005.","journal-title":"Hematol Oncol Clin North Am"},{"issue":"4","key":"4423_CR104","doi-asserted-by":"publisher","DOI":"10.1016\/j.lpm.2023.104202","volume":"52","author":"P Connes","year":"2023","unstructured":"Connes P, Renoux C, Joly P, Nader E. Vascular pathophysiology of Sickle Cell Disease. Presse Med. 2023;52(4):104202. https:\/\/doi.org\/10.1016\/j.lpm.2023.104202.","journal-title":"Presse Med"},{"issue":"1","key":"4423_CR105","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1053\/j.seminhematol.2021.12.002","volume":"59","author":"V Giudice","year":"2022","unstructured":"Giudice V, Selleri C. Aplastic anemia: pathophysiology. Semin Hematol. 2022;59(1):13\u201320. https:\/\/doi.org\/10.1053\/j.seminhematol.2021.12.002.","journal-title":"Semin Hematol"},{"key":"4423_CR106","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2025.112974","volume":"212","author":"J Wang","year":"2025","unstructured":"Wang J, Xin Y, Dong Z, Li S, Yang G. The interplay between the immune microenvironment and bone aging: from molecular mechanisms to therapeutic interventions. Exp Gerontol. 2025;212:112974. https:\/\/doi.org\/10.1016\/j.exger.2025.112974.","journal-title":"Exp Gerontol"},{"issue":"3","key":"4423_CR107","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.ccell.2017.08.001","volume":"32","author":"D Passaro","year":"2017","unstructured":"Passaro D, Di Tullio A, Abarrategi A, Rouault-Pierre K, Foster K, Ariza-McNaughton L, et al. Increased vascular permeability in the bone marrow microenvironment contributes to disease progression and drug response in acute myeloid leukemia. Cancer Cell. 2017;32(3):324-341.e6. https:\/\/doi.org\/10.1016\/j.ccell.2017.08.001.","journal-title":"Cancer Cell"},{"issue":"4","key":"4423_CR108","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1161\/CIRCRESAHA.118.313302","volume":"123","author":"K Vandoorne","year":"2018","unstructured":"Vandoorne K, Rohde D, Kim HY, Courties G, Wojtkiewicz G, Honold L, et al. NEW METHODS IN CARDIOVASCULAR BIOLOGY. Circ Res. 2018;123(4):415\u201327. https:\/\/doi.org\/10.1161\/CIRCRESAHA.118.313302.","journal-title":"Circ Res"},{"issue":"3","key":"4423_CR109","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.stem.2015.02.014","volume":"16","author":"K Schepers","year":"2015","unstructured":"Schepers K, Campbell TB, Passegu\u00e9 E. Normal and leukemic stem cell niches: insights and therapeutic opportunities. Cell Stem Cell. 2015;16(3):254\u201367. https:\/\/doi.org\/10.1016\/j.stem.2015.02.014.","journal-title":"Cell Stem Cell"},{"issue":"5","key":"4423_CR110","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.blre.2017.03.004","volume":"31","author":"MS Shafat","year":"2017","unstructured":"Shafat MS, Gnaneswaran B, Bowles KM, Rushworth SA. The bone marrow microenvironment \u2013 home of the leukemic blasts. Blood Rev. 2017;31(5):277\u201386. https:\/\/doi.org\/10.1016\/j.blre.2017.03.004.","journal-title":"Blood Rev"},{"issue":"3","key":"4423_CR111","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.ccell.2017.08.001","volume":"32","author":"D Passaro","year":"2017","unstructured":"Passaro D, Di Tullio A, Abarrategi A, Rouault-Pierre K, Foster K, Ariza-McNaughton L, et al. Increased vascular permeability in the bone marrow microenvironment contributes to disease progression and drug response in acute myeloid leukemia. Cancer Cell. 2017;32(3):324-341.e6. https:\/\/doi.org\/10.1016\/j.ccell.2017.08.001.","journal-title":"Cancer Cell"},{"issue":"11","key":"4423_CR112","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/nrd.2016.175","volume":"15","author":"P Horvath","year":"2016","unstructured":"Horvath P, Aulner N, Bickle M, Davies AM, Nery ED, Ebner D, et al. Screening out irrelevant cell-based models of disease. Nat Rev Drug Discov. 2016;15(11):751\u201369. https:\/\/doi.org\/10.1038\/nrd.2016.175.","journal-title":"Nat Rev Drug Discov"},{"issue":"8","key":"4423_CR113","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/s44222-023-00063-3","volume":"1","author":"A Loewa","year":"2023","unstructured":"Loewa A, Feng JJ, Hedtrich S. Human disease models in drug development. Nat Rev Bioeng. 2023;1(8):545\u201359. https:\/\/doi.org\/10.1038\/s44222-023-00063-3.","journal-title":"Nat Rev Bioeng"},{"issue":"3","key":"4423_CR114","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.stem.2018.01.002","volume":"22","author":"PE Bourgine","year":"2018","unstructured":"Bourgine PE, Martin I, Schroeder T. Engineering human bone marrow proxies. Cell Stem Cell. 2018;22(3):298\u2013301. https:\/\/doi.org\/10.1016\/j.stem.2018.01.002.","journal-title":"Cell Stem Cell"},{"issue":"5","key":"4423_CR115","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1038\/s41592-024-02172-2","volume":"21","author":"S Frenz-Wiessner","year":"2024","unstructured":"Frenz-Wiessner S, Fairley SD, Buser M, Goek I, Salewskij K, Jonsson G, et al. Generation of complex bone marrow organoids from human induced pluripotent stem cells. Nat Methods. 2024;21(5):868\u201381. https:\/\/doi.org\/10.1038\/s41592-024-02172-2.","journal-title":"Nat Methods"},{"issue":"2","key":"4423_CR116","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1158\/2159-8290.CD-22-0199","volume":"13","author":"AO Khan","year":"2023","unstructured":"Khan AO, Rodriguez-Romera A, Reyat JS, Olijnik AA, Colombo M, Wang G, et al. Human bone marrow organoids for disease modeling, discovery, and validation of therapeutic targets in hematologic malignancies. Cancer Discov. 2023;13(2):364\u201385. https:\/\/doi.org\/10.1158\/2159-8290.CD-22-0199.","journal-title":"Cancer Discov"},{"issue":"1","key":"4423_CR117","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1182\/bloodadvances.2024013361","volume":"9","author":"K Ren","year":"2025","unstructured":"Ren K, Li E, Aydemir I, Liu Y, Han X, Bi H, et al. Development of iPSC-derived human bone marrow organoid for autonomous hematopoiesis and patient-derived HSPC engraftment. Blood Adv. 2025;9(1):54\u201365. https:\/\/doi.org\/10.1182\/bloodadvances.2024013361.","journal-title":"Blood Adv"},{"issue":"4","key":"4423_CR118","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/s41551-019-0495-z","volume":"4","author":"DB Chou","year":"2020","unstructured":"Chou DB, Frismantas V, Milton Y, David R, Pop-Damkov P, Ferguson D, et al. On-chip recapitulation of clinical bone marrow toxicities and patient-specific pathophysiology. Nat Biomed Eng. 2020;4(4):394\u2013406. https:\/\/doi.org\/10.1038\/s41551-019-0495-z.","journal-title":"Nat Biomed Eng"},{"key":"4423_CR119","doi-asserted-by":"publisher","DOI":"10.1038\/s41551-025-01428-2","author":"C Ma","year":"2025","unstructured":"Ma C, Wang H, Liu L, Chen R, Mukherjee N, Tong J, et al. Bioengineered immunocompetent preclinical trial-on-chip tool enables screening of CAR T cell therapy for leukaemia. Nat Biomed Eng. 2025. https:\/\/doi.org\/10.1038\/s41551-025-01428-2.","journal-title":"Nat Biomed Eng"},{"issue":"1","key":"4423_CR120","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-025-08137-1","volume":"8","author":"L Koenig","year":"2025","unstructured":"Koenig L, Juglair L, Tao TP, Fischer S, Clausen I, Imhof-Jung S, et al. A microfluidic bone marrow chip for the safety profiling of biologics in pre-clinical drug development. Commun Biol. 2025;8(1):754. https:\/\/doi.org\/10.1038\/s42003-025-08137-1.","journal-title":"Commun Biol"},{"key":"4423_CR121","unstructured":"Center for Drug Evaluation and. Roadmap to Reducing Animal Testing in Preclinical Safety Studies [Internet]. 2025 [cited 2025 Aug 26]. Available from: https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-announces-plan-phase-out-animal-testing-requirement-monoclonal-antibodies-and-other-drugs?utm_source=chatgpt.com"},{"issue":"21","key":"4423_CR122","doi-asserted-by":"publisher","DOI":"10.1172\/JCI175824","volume":"133","author":"PJH Zushin","year":"2023","unstructured":"Zushin PJH, Mukherjee S, Wu JC. FDA Modernization Act 2.0: transitioning beyond animal models with human cells, organoids, and AI\/ML-based approaches. J Clin Invest. 2023;133(21):e175824. https:\/\/doi.org\/10.1172\/JCI175824.","journal-title":"J Clin Invest"},{"issue":"8","key":"4423_CR123","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1158\/1078-0432.CCR-10-1959","volume":"17","author":"S Cai","year":"2011","unstructured":"Cai S, Wang H, Bailey B, Ernstberger A, Juliar BE, Sinn AL, et al. Humanized bone marrow mouse model as a preclinical tool to assess therapy-mediated hematotoxicity. Clin Cancer Res. 2011;17(8):2195\u2013206. https:\/\/doi.org\/10.1158\/1078-0432.CCR-10-1959.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"4423_CR124","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1146\/annurev-pathol-052016-100332","volume":"12","author":"NC Walsh","year":"2017","unstructured":"Walsh NC, Kenney LL, Jangalwe S, Aryee KE, Greiner DL, Brehm MA, et al. Humanized mouse models of clinical disease. Annu Rev Pathol Mech Dis. 2017;12(1):187\u2013215. https:\/\/doi.org\/10.1146\/annurev-pathol-052016-100332.","journal-title":"Annu Rev Pathol Mech Dis"},{"issue":"10","key":"4423_CR125","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.745","volume":"5","author":"V Janitri","year":"2024","unstructured":"Janitri V, ArulJothi KN, Ravi Mythili VM, Singh SK, Prasher P, Gupta G, et al. The roles of patient\u2010derived xenograft models and artificial intelligence toward precision medicine. MedComm. 2024;5(10):e745. https:\/\/doi.org\/10.1002\/mco2.745.","journal-title":"MedComm"},{"key":"4423_CR126","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2022.114236","volume":"184","author":"P Vervaeke","year":"2022","unstructured":"Vervaeke P, Borgos SE, Sanders NN, Combes F. Regulatory guidelines and preclinical tools to study the biodistribution of RNA therapeutics. Adv Drug Deliv Rev. 2022;184:114236. https:\/\/doi.org\/10.1016\/j.addr.2022.114236.","journal-title":"Adv Drug Deliv Rev"},{"issue":"8","key":"4423_CR127","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1016\/j.immuni.2022.07.008","volume":"55","author":"K Medetgul-Ernar","year":"2022","unstructured":"Medetgul-Ernar K, Davis MM. Standing on the shoulders of mice. Immunity. 2022;55(8):1343\u201353. https:\/\/doi.org\/10.1016\/j.immuni.2022.07.008.","journal-title":"Immunity"},{"issue":"11","key":"4423_CR128","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1016\/j.immuni.2022.10.014","volume":"55","author":"R Verbeke","year":"2022","unstructured":"Verbeke R, Hogan MJ, Lor\u00e9 K, Pardi N. Innate immune mechanisms of mRNA vaccines. Immunity. 2022;55(11):1993\u20132005. https:\/\/doi.org\/10.1016\/j.immuni.2022.10.014.","journal-title":"Immunity"},{"issue":"3","key":"4423_CR129","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/s41565-021-01030-y","volume":"17","author":"MZC Hatit","year":"2022","unstructured":"Hatit MZC, Lokugamage MP, Dobrowolski CN, Paunovska K, Ni H, Zhao K, et al. Species-dependent in vivo mRNA delivery and cellular responses to nanoparticles. Nat Nanotechnol. 2022;17(3):310\u20138. https:\/\/doi.org\/10.1038\/s41565-021-01030-y.","journal-title":"Nat Nanotechnol"},{"key":"4423_CR130","doi-asserted-by":"publisher","DOI":"10.1016\/j.cis.2020.102261","volume":"284","author":"A Zhang","year":"2020","unstructured":"Zhang A, Meng K, Liu Y, Pan Y, Qu W, Chen D, et al. Absorption, distribution, metabolism, and excretion of nanocarriers in vivo and their influences. Adv Colloid Interface Sci. 2020;284:102261. https:\/\/doi.org\/10.1016\/j.cis.2020.102261.","journal-title":"Adv Colloid Interface Sci"},{"issue":"49","key":"4423_CR131","doi-asserted-by":"publisher","first-page":"17095","DOI":"10.1021\/jacs.8b08976","volume":"140","author":"CD Sago","year":"2018","unstructured":"Sago CD, Lokugamage MP, Islam FZ, Krupczak BR, Sato M, Dahlman JE. Nanoparticles that deliver RNA to bone marrow identified by in vivo directed evolution. J Am Chem Soc. 2018;140(49):17095\u2013105. https:\/\/doi.org\/10.1021\/jacs.8b08976.","journal-title":"J Am Chem Soc"},{"issue":"8","key":"4423_CR132","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/nnano.2014.84","volume":"9","author":"JE Dahlman","year":"2014","unstructured":"Dahlman JE, Barnes C, Khan OF, Thiriot A, Jhunjunwala S, Shaw TE, et al. In vivo endothelial siRNA delivery using polymeric nanoparticles with low molecular weight. Nat Nanotechnol. 2014;9(8):648\u201355. https:\/\/doi.org\/10.1038\/nnano.2014.84.","journal-title":"Nat Nanotechnol"},{"issue":"19","key":"4423_CR133","doi-asserted-by":"publisher","first-page":"13151","DOI":"10.1021\/jacs.4c00474","volume":"146","author":"H Orlikowska-Rzeznik","year":"2024","unstructured":"Orlikowska-Rzeznik H, Versluis J, Bakker HJ, Piatkowski L. Cholesterol changes interfacial water alignment in model cell membranes. J Am Chem Soc. 2024;146(19):13151\u201362. https:\/\/doi.org\/10.1021\/jacs.4c00474.","journal-title":"J Am Chem Soc"},{"issue":"52","key":"4423_CR134","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2109256118","volume":"118","author":"SA Dilliard","year":"2021","unstructured":"Dilliard SA, Cheng Q, Siegwart DJ. On the mechanism of tissue-specific mRNA delivery by selective organ targeting nanoparticles. Proc Natl Acad Sci U S A. 2021;118(52):e2109256118. https:\/\/doi.org\/10.1073\/pnas.2109256118.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4423_CR135","doi-asserted-by":"publisher","DOI":"10.1002\/adfm.202525076","author":"BI Hanafy","year":"2026","unstructured":"Hanafy BI, Lu CE, Liu K, Gallud A. PRELIVE: a framework for predicting lipid nanoparticles in vivo efficacy and reducing reliance on animal testing. Adv Funct Mater. 2026. https:\/\/doi.org\/10.1002\/adfm.202525076.","journal-title":"Adv Funct Mater"},{"issue":"2","key":"4423_CR136","doi-asserted-by":"publisher","DOI":"10.1002\/mba2.50","volume":"2","author":"X Song","year":"2023","unstructured":"Song X, Nan F, Zhang D. A new multiomics nanoparticle delivery system \u201cSENT-seq\u201d: to support the development of mRNA therapies. MedComm Biomater Appl. 2023;2(2):e50. https:\/\/doi.org\/10.1002\/mba2.50.","journal-title":"MedComm Biomater Appl"},{"issue":"8","key":"4423_CR137","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1038\/s41565-022-01146-9","volume":"17","author":"C Dobrowolski","year":"2022","unstructured":"Dobrowolski C, Paunovska K, Schrader Echeverri E, Loughrey D, Da Silva Sanchez AJ, Ni H, et al. Nanoparticle single-cell multiomic readouts reveal that cell heterogeneity influences lipid nanoparticle-mediated messenger RNA delivery. Nat Nanotechnol. 2022;17(8):871\u20139. https:\/\/doi.org\/10.1038\/s41565-022-01146-9.","journal-title":"Nat Nanotechnol"},{"issue":"4","key":"4423_CR138","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/nnano.2015.330","volume":"11","author":"S Sch\u00f6ttler","year":"2016","unstructured":"Sch\u00f6ttler S, Becker G, Winzen S, Steinbach T, Mohr K, Landfester K, et al. Protein adsorption is required for stealth effect of poly(ethylene glycol)- and poly(phosphoester)-coated nanocarriers. Nat Nanotechnol. 2016;11(4):372\u20137. https:\/\/doi.org\/10.1038\/nnano.2015.330.","journal-title":"Nat Nanotechnol"},{"issue":"4","key":"4423_CR139","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.bbrc.2016.10.121","volume":"480","author":"M Aoyama","year":"2016","unstructured":"Aoyama M, Hata K, Higashisaka K, Nagano K, Yoshioka Y, Tsutsumi Y. Clusterin in the protein corona plays a key role in the stealth effect of nanoparticles against phagocytes. Biochem Biophys Res Commun. 2016;480(4):690\u20135. https:\/\/doi.org\/10.1016\/j.bbrc.2016.10.121.","journal-title":"Biochem Biophys Res Commun"},{"issue":"7","key":"4423_CR140","doi-asserted-by":"publisher","first-page":"2938","DOI":"10.1021\/acs.nanolett.3c00304","volume":"23","author":"D Shi","year":"2023","unstructured":"Shi D, Toyonaga S, Anderson DG. In vivo RNA delivery to hematopoietic stem and progenitor cells via targeted lipid nanoparticles. Nano Lett. 2023;23(7):2938\u201344. https:\/\/doi.org\/10.1021\/acs.nanolett.3c00304.","journal-title":"Nano Lett"},{"issue":"22","key":"4423_CR141","doi-asserted-by":"publisher","first-page":"9926","DOI":"10.1021\/jacs.2c02706","volume":"144","author":"L Xue","year":"2022","unstructured":"Xue L, Gong N, Shepherd SJ, Xiong X, Liao X, Han X, et al. Rational design of bisphosphonate lipid-like materials for mRNA delivery to the bone microenvironment. J Am Chem Soc. 2022;144(22):9926\u201337. https:\/\/doi.org\/10.1021\/jacs.2c02706.","journal-title":"J Am Chem Soc"},{"issue":"6","key":"4423_CR142","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15061603","volume":"15","author":"LE Swart","year":"2023","unstructured":"Swart LE, Fens MHAM, van Oort A, Waranecki P, Mata Casimiro LD, Tuk D, et al. Increased bone marrow uptake and accumulation of Very-Late Antigen-4 targeted lipid nanoparticles. Pharmaceutics. 2023;15(6):1603. https:\/\/doi.org\/10.3390\/pharmaceutics15061603.","journal-title":"Pharmaceutics"},{"issue":"5","key":"4423_CR143","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1021\/acs.molpharmaceut.7b01169","volume":"15","author":"J Mai","year":"2018","unstructured":"Mai J, Li X, Zhang G, Huang Y, Xu R, Shen Q, et al. DNA thioaptamer with homing specificity to lymphoma bone marrow involvement. Mol Pharm. 2018;15(5):1814\u201325. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.7b01169.","journal-title":"Mol Pharm"},{"issue":"3","key":"4423_CR144","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/nm.3791","volume":"21","author":"C Liang","year":"2015","unstructured":"Liang C, Guo B, Wu H, Shao N, Li D, Liu J, et al. Aptamer-functionalized lipid nanoparticles targeting osteoblasts as a novel RNA interference\u2013based bone anabolic strategy. Nat Med. 2015;21(3):288\u201394. https:\/\/doi.org\/10.1038\/nm.3791.","journal-title":"Nat Med"},{"issue":"25","key":"4423_CR145","doi-asserted-by":"publisher","first-page":"26838","DOI":"10.1021\/acsomega.4c02466","volume":"9","author":"S Kumar","year":"2024","unstructured":"Kumar S, Mohan A, Sharma NR, Kumar A, Girdhar M, Malik T, et al. Computational frontiers in aptamer-based nanomedicine for precision therapeutics: a comprehensive review. ACS Omega. 2024;9(25):26838\u201362. https:\/\/doi.org\/10.1021\/acsomega.4c02466.","journal-title":"ACS Omega"},{"issue":"8","key":"4423_CR146","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1016\/j.ymthe.2020.06.015","volume":"28","author":"AJ Debacker","year":"2020","unstructured":"Debacker AJ, Voutila J, Catley M, Blakey D, Habib N. Delivery of oligonucleotides to the liver with GalNAc: from research to registered therapeutic drug. Mol Ther. 2020;28(8):1759\u201371. https:\/\/doi.org\/10.1016\/j.ymthe.2020.06.015.","journal-title":"Mol Ther"},{"issue":"7","key":"4423_CR147","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.7150\/thno.18136","volume":"7","author":"X Zhu","year":"2017","unstructured":"Zhu X, Tao W, Liu D, Wu J, Guo Z, Ji X, et al. Surface de-PEGylation controls nanoparticle-mediated siRNA delivery in vitro and in vivo. Theranostics. 2017;7(7):1990\u20132002. https:\/\/doi.org\/10.7150\/thno.18136.","journal-title":"Theranostics"},{"issue":"12","key":"4423_CR148","doi-asserted-by":"publisher","first-page":"4238","DOI":"10.1039\/D2BM01846B","volume":"11","author":"LE Waggoner","year":"2023","unstructured":"Waggoner LE, Miyasaki KF, Kwon EJ. Analysis of PEG-lipid anchor length on lipid nanoparticle pharmacokinetics and activity in a mouse model of traumatic brain injury. Biomater Sci. 2023;11(12):4238\u201353. https:\/\/doi.org\/10.1039\/D2BM01846B.","journal-title":"Biomater Sci"},{"issue":"12","key":"4423_CR149","doi-asserted-by":"publisher","DOI":"10.1002\/adma.201906128","volume":"32","author":"S Ramishetti","year":"2020","unstructured":"Ramishetti S, Hazan\u2010Halevy I, Palakuri R, Chatterjee S, Naidu Gonna S, Dammes N, et al. A combinatorial library of lipid nanoparticles for RNA delivery to leukocytes. Adv Mater. 2020;32(12):1906128. https:\/\/doi.org\/10.1002\/adma.201906128.","journal-title":"Adv Mater"},{"issue":"6","key":"4423_CR150","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1016\/j.ymthe.2018.03.010","volume":"26","author":"S Sabnis","year":"2018","unstructured":"Sabnis S, Kumarasinghe ES, Salerno T, Mihai C, Ketova T, Senn JJ, et al. A novel amino lipid series for mRNA delivery: improved endosomal escape and sustained pharmacology and safety in non-human primates. Mol Ther. 2018;26(6):1509\u201319. https:\/\/doi.org\/10.1016\/j.ymthe.2018.03.010.","journal-title":"Mol Ther"},{"issue":"3","key":"4423_CR151","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1073\/pnas.1520756113","volume":"113","author":"K Zhou","year":"2016","unstructured":"Zhou K, Nguyen LH, Miller JB, Yan Y, Kos P, Xiong H, et al. Modular degradable dendrimers enable small RNAs to extend survival in an aggressive liver cancer model. Proc Natl Acad Sci U S A. 2016;113(3):520\u20135. https:\/\/doi.org\/10.1073\/pnas.1520756113.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"4423_CR152","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-021-02441-2","volume":"4","author":"MJ Carrasco","year":"2021","unstructured":"Carrasco MJ, Alishetty S, Alameh MG, Said H, Wright L, Paige M, et al. Ionization and structural properties of mRNA lipid nanoparticles influence expression in intramuscular and intravascular administration. Commun Biol. 2021;4(1):956. https:\/\/doi.org\/10.1038\/s42003-021-02441-2.","journal-title":"Commun Biol"},{"issue":"33","key":"4423_CR153","doi-asserted-by":"publisher","DOI":"10.1002\/adma.201606944","volume":"29","author":"OS Fenton","year":"2017","unstructured":"Fenton OS, Kauffman KJ, Kaczmarek JC, McClellan RL, Jhunjhunwala S, Tibbitt MW, et al. Synthesis and biological evaluation of ionizable lipid materials for the in vivo delivery of messenger RNA to B lymphocytes. Adv Mater. 2017;29(33):1606944. https:\/\/doi.org\/10.1002\/adma.201606944.","journal-title":"Adv Mater"},{"issue":"6","key":"4423_CR154","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.tips.2021.03.002","volume":"42","author":"P Patel","year":"2021","unstructured":"Patel P, Ibrahim NM, Cheng K. The importance of apparent pKa in the development of nanoparticles encapsulating siRNA and mRNA. Trends Pharmacol Sci. 2021;42(6):448\u201360. https:\/\/doi.org\/10.1016\/j.tips.2021.03.002.","journal-title":"Trends Pharmacol Sci"},{"issue":"9","key":"4423_CR155","doi-asserted-by":"publisher","first-page":"3185","DOI":"10.1021\/acs.langmuir.2c02794","volume":"39","author":"IV Zhigaltsev","year":"2023","unstructured":"Zhigaltsev IV, Cullis PR. Morphological behavior of liposomes and lipid nanoparticles. Langmuir. 2023;39(9):3185\u201393. https:\/\/doi.org\/10.1021\/acs.langmuir.2c02794.","journal-title":"Langmuir"},{"issue":"31","key":"4423_CR156","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202303370","volume":"35","author":"MHY Cheng","year":"2023","unstructured":"Cheng MHY, Leung J, Zhang Y, Strong C, Basha G, Momeni A, et al. Induction of bleb structures in lipid nanoparticle formulations of mRNA leads to improved transfection potency. Adv Mater. 2023;35(31):2303370. https:\/\/doi.org\/10.1002\/adma.202303370.","journal-title":"Adv Mater"},{"key":"4423_CR157","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2024.124942","volume":"668","author":"B Binici","year":"2025","unstructured":"Binici B, Borah A, Watts JA, McLoughlin D, Perrie Y. The influence of citrate buffer molarity on mRNA-LNPs: exploring factors beyond general critical quality attributes. Int J Pharm. 2025;668:124942. https:\/\/doi.org\/10.1016\/j.ijpharm.2024.124942.","journal-title":"Int J Pharm"},{"issue":"45","key":"4423_CR158","doi-asserted-by":"publisher","first-page":"21733","DOI":"10.1039\/C9NR09347H","volume":"11","author":"JA Kulkarni","year":"2019","unstructured":"Kulkarni JA, Witzigmann D, Leung J, Tam YYC, Cullis PR. On the role of helper lipids in lipid nanoparticle formulations of siRNA. Nanoscale. 2019;11(45):21733\u20139. https:\/\/doi.org\/10.1039\/C9NR09347H.","journal-title":"Nanoscale"},{"issue":"1","key":"4423_CR159","doi-asserted-by":"publisher","first-page":"4135","DOI":"10.1038\/s41467-025-58523-w","volume":"16","author":"MHY Cheng","year":"2025","unstructured":"Cheng MHY, Zhang Y, Fox K, Leung J, Strong C, Kang E, et al. Liposomal lipid nanoparticles for extrahepatic delivery of mRNA. Nat Commun. 2025;16(1):4135. https:\/\/doi.org\/10.1038\/s41467-025-58523-w.","journal-title":"Nat Commun"},{"issue":"10","key":"4423_CR160","doi-asserted-by":"publisher","first-page":"9094","DOI":"10.1021\/acsami.7b16096","volume":"10","author":"H Zhang","year":"2018","unstructured":"Zhang H, Wu T, Yu W, Ruan S, He Q, Gao H. Ligand size and conformation affect the behavior of nanoparticles coated with in vitro and in vivo protein corona. ACS Appl Mater Interfaces. 2018;10(10):9094\u2013103. https:\/\/doi.org\/10.1021\/acsami.7b16096.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"8","key":"4423_CR161","doi-asserted-by":"publisher","first-page":"8142","DOI":"10.1021\/acsnano.5b03300","volume":"9","author":"M Hadjidemetriou","year":"2015","unstructured":"Hadjidemetriou M, Al-Ahmady Z, Mazza M, Collins RF, Dawson K, Kostarelos K. In vivo biomolecule corona around blood-circulating, clinically used and antibody-targeted lipid bilayer nanoscale vesicles. ACS Nano. 2015;9(8):8142\u201356. https:\/\/doi.org\/10.1021\/acsnano.5b03300.","journal-title":"ACS Nano"},{"key":"4423_CR162","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.jconrel.2025.01.047","volume":"379","author":"UJ Bj\u00f6rgvinsd\u00f3ttir","year":"2025","unstructured":"Bj\u00f6rgvinsd\u00f3ttir UJ, Larsen JB, Bak M, Andresen TL, M\u00fcnter R. Targeting antibodies dissociate from drug delivery liposomes during blood circulation. J Control Release. 2025;379:982\u201392. https:\/\/doi.org\/10.1016\/j.jconrel.2025.01.047.","journal-title":"J Control Release"},{"issue":"5","key":"4423_CR163","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202409945","volume":"37","author":"MH Zaleski","year":"2025","unstructured":"Zaleski MH, Chase LS, Hood ED, Wang Z, Nong J, Espy CL, et al. Conjugation chemistry markedly impacts toxicity and biodistribution of targeted nanoparticles, mediated by complement activation. Adv Mater. 2025;37(5):2409945. https:\/\/doi.org\/10.1002\/adma.202409945.","journal-title":"Adv Mater"},{"key":"4423_CR164","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-025-01237-x","author":"S Wang","year":"2025","unstructured":"Wang S, Weissman D, Dong Y. RNA chemistry and therapeutics. Nat Rev Drug Discov. 2025. https:\/\/doi.org\/10.1038\/s41573-025-01237-x.","journal-title":"Nat Rev Drug Discov"},{"key":"4423_CR165","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.jconrel.2020.03.022","volume":"322","author":"K Son","year":"2020","unstructured":"Son K, Ueda M, Taguchi K, Maruyama T, Takeoka S, Ito Y. Evasion of the accelerated blood clearance phenomenon by polysarcosine coating of liposomes. J Control Release. 2020;322:209\u201316. https:\/\/doi.org\/10.1016\/j.jconrel.2020.03.022.","journal-title":"J Control Release"},{"key":"4423_CR166","doi-asserted-by":"publisher","DOI":"10.1038\/s41565-025-01974-5","author":"S Omo-Lamai","year":"2025","unstructured":"Omo-Lamai S. Limiting endosomal damage sensing reduces inflammation triggered by lipid nanoparticle endosomal escape. Nat Nanotechnol. 2025. https:\/\/doi.org\/10.1038\/s41565-025-01974-5.","journal-title":"Nat Nanotechnol"},{"key":"4423_CR167","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2025.03.018","author":"TE Papp","year":"2025","unstructured":"Papp TE, Zeng J, Shahnawaz H, Akyianu A, Breda L, Yadegari A, et al. CD47 peptide-cloaked lipid nanoparticles promote cell-specific mRNA delivery. Mol Ther. 2025. https:\/\/doi.org\/10.1016\/j.ymthe.2025.03.018.","journal-title":"Mol Ther"},{"key":"4423_CR168","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-025-01029-7","author":"Z Wang","year":"2025","unstructured":"Wang Z, Li W, Jiang Y, Ma T, Li M, Wu S, et al. A sphingolipid-derived paclitaxel nanovesicle enhances efficacy of combination therapies in triple-negative breast cancer and pancreatic cancer. Nat Cancer. 2025. https:\/\/doi.org\/10.1038\/s43018-025-01029-7.","journal-title":"Nat Cancer"},{"key":"4423_CR169","doi-asserted-by":"publisher","DOI":"10.1038\/s41563-025-02284-w","author":"Y Feng","year":"2025","unstructured":"Feng Y, Tai W, Huang P, Qi S, Yu X, Li M, et al. Albumin-recruiting lipid nanoparticle potentiates the safety and efficacy of mRNA vaccines by avoiding liver accumulation. Nat Mater. 2025. https:\/\/doi.org\/10.1038\/s41563-025-02284-w.","journal-title":"Nat Mater"},{"issue":"6","key":"4423_CR170","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1007\/s12015-021-10272-1","volume":"17","author":"JB Menendez-Gonzalez","year":"2021","unstructured":"Menendez-Gonzalez JB, Hoggatt J. Hematopoietic stem cell mobilization: current collection approaches, stem cell heterogeneity, and a proposed new method for stem cell transplant conditioning. Stem Cell Rev Rep. 2021;17(6):1939\u201353. https:\/\/doi.org\/10.1007\/s12015-021-10272-1.","journal-title":"Stem Cell Rev Rep"},{"key":"4423_CR171","unstructured":"EU Innovation Network (EU-IN) | European Medicines Agency (EMA). Nanotechnology-based medicinal products for human use [Internet]. 2025 [cited 2025 Aug 13]. Available from: https:\/\/www.ema.europa.eu\/en\/committees\/working-parties-other-groups\/eu-innovation-network-eu"},{"key":"4423_CR172","unstructured":"Research C for DE and. Drug Products, Including Biological Products, that Contain Nanomaterials - Guidance for Industry [Internet]. FDA; 2022 [cited 2025 Aug 13]. Available from: https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/drug-products-including-biological-products-contain-nanomaterials-guidance-industry"},{"issue":"9","key":"4423_CR173","doi-asserted-by":"publisher","first-page":"3034","DOI":"10.1016\/j.ymthe.2022.06.012","volume":"30","author":"G Basha","year":"2022","unstructured":"Basha G, Cottle AG, Pretheeban T, Chan KYt, Witzigmann D, Young RN, et al. Lipid nanoparticle-mediated silencing of osteogenic suppressor GNAS leads to osteogenic differentiation of mesenchymal stem cells in vivo. Mol Ther. 2022;30(9):3034\u201351. https:\/\/doi.org\/10.1016\/j.ymthe.2022.06.012.","journal-title":"Mol Ther"},{"issue":"7","key":"4423_CR174","doi-asserted-by":"publisher","first-page":"3273","DOI":"10.1039\/D5MD00115C","volume":"16","author":"EL Dane","year":"2025","unstructured":"Dane EL, Pote AR, Hemmerling M, Czechtizky W, Zhou L, Bak A. New ionizable lipids for non-viral mRNA delivery with secondary amine cyclic ether head groups. RSC Med Chem. 2025;16(7):3273\u201380. https:\/\/doi.org\/10.1039\/D5MD00115C.","journal-title":"RSC Med Chem"},{"issue":"8","key":"4423_CR175","doi-asserted-by":"publisher","first-page":"11769","DOI":"10.1021\/acsnano.2c04543","volume":"16","author":"Y Ju","year":"2022","unstructured":"Ju Y, Lee WS, Pilkington EH, Kelly HG, Li S, Selva KJ, et al. Anti-PEG antibodies boosted in humans by SARS-CoV-2 lipid nanoparticle mRNA vaccine. ACS Nano. 2022;16(8):11769\u201380. https:\/\/doi.org\/10.1021\/acsnano.2c04543.","journal-title":"ACS Nano"},{"issue":"31","key":"4423_CR176","doi-asserted-by":"publisher","first-page":"4561","DOI":"10.1016\/j.vaccine.2023.06.009","volume":"41","author":"GT Kozma","year":"2023","unstructured":"Kozma GT, M\u00e9sz\u00e1ros T, Ber\u00e9nyi P, Facsk\u00f3 R, Patk\u00f3 Z, Ol\u00e1h CZ, et al. Role of anti-polyethylene glycol (PEG) antibodies in the allergic reactions to PEG-containing COVID-19 vaccines: evidence for immunogenicity of PEG. Vaccine. 2023;41(31):4561\u201370. https:\/\/doi.org\/10.1016\/j.vaccine.2023.06.009.","journal-title":"Vaccine"},{"issue":"41","key":"4423_CR177","doi-asserted-by":"publisher","first-page":"14323","DOI":"10.1021\/ja504390x","volume":"136","author":"EM Pelegri-O\u2019Day","year":"2014","unstructured":"Pelegri-O\u2019Day EM, Lin EW, Maynard HD. Therapeutic protein\u2013polymer conjugates: advancing beyond PEGylation. J Am Chem Soc. 2014;136(41):14323\u201332. https:\/\/doi.org\/10.1021\/ja504390x.","journal-title":"J Am Chem Soc"},{"issue":"11","key":"4423_CR178","doi-asserted-by":"publisher","first-page":"10634","DOI":"10.1021\/acsanm.0c01834","volume":"3","author":"SS Nogueira","year":"2020","unstructured":"Nogueira SS, Schlegel A, Maxeiner K, Weber B, Barz M, Schroer MA, et al. Polysarcosine-functionalized lipid nanoparticles for therapeutic mRNA delivery. ACS Appl Nano Mater. 2020;3(11):10634\u201345. https:\/\/doi.org\/10.1021\/acsanm.0c01834.","journal-title":"ACS Appl Nano Mater"},{"issue":"7","key":"4423_CR179","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1021\/acs.bioconjchem.8b00237","volume":"29","author":"Y Hu","year":"2018","unstructured":"Hu Y, Hou Y, Wang H, Lu H. Polysarcosine as an alternative to PEG for therapeutic protein conjugation. Bioconjug Chem. 2018;29(7):2232\u20138. https:\/\/doi.org\/10.1021\/acs.bioconjchem.8b00237.","journal-title":"Bioconjug Chem"},{"issue":"6","key":"4423_CR180","doi-asserted-by":"publisher","first-page":"5834","DOI":"10.1021\/acsnano.8b01806","volume":"12","author":"R Tavano","year":"2018","unstructured":"Tavano R, Gabrielli L, Lubian E, Fedeli C, Visentin S, Polverino De Laureto P, et al. C1q-mediated complement activation and C3 opsonization trigger recognition of stealth Poly(2-methyl-2-oxazoline)-coated silica nanoparticles by human phagocytes. ACS Nano. 2018;12(6):5834\u201347. https:\/\/doi.org\/10.1021\/acsnano.8b01806.","journal-title":"ACS Nano"},{"issue":"1","key":"4423_CR181","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-57648-2","volume":"16","author":"R Tavano","year":"2025","unstructured":"Tavano R, Morillas-Becerril L, Geffner-Smith A, Ronzani G, Gervasutti R, Arrigoni G, et al. Species differences in opsonization and phagocyte recognition of preclinical poly-2-alkyl-2-oxazoline-coated nanoparticles. Nat Commun. 2025;16(1):2642. https:\/\/doi.org\/10.1038\/s41467-025-57648-2.","journal-title":"Nat Commun"},{"issue":"8","key":"4423_CR182","doi-asserted-by":"publisher","first-page":"2302712","DOI":"10.1002\/adhm.202302712","volume":"13","author":"M Berger","year":"2024","unstructured":"Berger M, Toussaint F, Ben Djemaa S, Maquoi E, Pendeville H, Evrard B, et al. Poly(N-methyl-N-vinylacetamide): A Strong Alternative to PEG for Lipid-Based Nanocarriers Delivering siRNA. Adv Healthc Mater. 2024;13(8):2302712. https:\/\/doi.org\/10.1002\/adhm.202302712.","journal-title":"Adv Healthc Mater"},{"key":"4423_CR183","unstructured":"Research C for DE and. Liposome Drug Products: Chemistry, Manufacturing, and Controls; Human Pharmacokinetics and Bioavailability; and Labeling Documentation [Internet]. FDA; 2018 [cited 2025 Sep 21]. Available from: https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/liposome-drug-products-chemistry-manufacturing-and-controls-human-pharmacokinetics-and"},{"key":"4423_CR184","unstructured":"European Medicines Agency (EMA). Surface coatings: general issues for consideration regarding parenteral administration of coated nanomedicine products - Scientific guideline [Internet]. 2013 [cited 2025 Aug 14]. Available from: https:\/\/www.ema.europa.eu\/en\/surface-coatings-general-issues-consideration-regarding-parenteral-administration-coated-nanomedicine-products-scientific-guideline"},{"issue":"46","key":"4423_CR185","doi-asserted-by":"publisher","first-page":"14036","DOI":"10.1021\/acs.langmuir.2c01492","volume":"38","author":"K An","year":"2022","unstructured":"An K, Kurek D, Mahadeo M, Zhang Y, Thewalt JL, Cullis PR, et al. On the influence of nucleic acid backbone modifications on lipid nanoparticle morphology. Langmuir. 2022;38(46):14036\u201343. https:\/\/doi.org\/10.1021\/acs.langmuir.2c01492.","journal-title":"Langmuir"},{"key":"4423_CR186","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.jcis.2024.06.158","volume":"674","author":"R M\u00fcnter","year":"2024","unstructured":"M\u00fcnter R, Larsen JB, Andresen TL. The vast majority of nucleic acid-loaded lipid nanoparticles contain cargo. J Colloid Interface Sci. 2024;674:139\u201344. https:\/\/doi.org\/10.1016\/j.jcis.2024.06.158.","journal-title":"J Colloid Interface Sci"},{"issue":"7","key":"4423_CR187","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.1002\/jps.21620","volume":"98","author":"WF Bayne","year":"2009","unstructured":"Bayne WF, Mayer LD, Swenson CE. Pharmacokinetics of CPX-351 (Cytarabine\/Daunorubicin HCl) liposome injection in the mouse. J Pharm Sci. 2009;98(7):2540\u20138. https:\/\/doi.org\/10.1002\/jps.21620.","journal-title":"J Pharm Sci"},{"issue":"1","key":"4423_CR188","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.leukres.2008.06.028","volume":"33","author":"P Tardi","year":"2009","unstructured":"Tardi P, Johnstone S, Harasym N, Xie S, Harasym T, Zisman N, et al. In vivo maintenance of synergistic Cytarabine:Daunorubicin ratios greatly enhances therapeutic efficacy. Leuk Res. 2009;33(1):129\u201339. https:\/\/doi.org\/10.1016\/j.leukres.2008.06.028.","journal-title":"Leuk Res"},{"issue":"1\u20132","key":"4423_CR189","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.ijpharm.2010.02.014","volume":"391","author":"A Dicko","year":"2010","unstructured":"Dicko A, Kwak S, Frazier AA, Mayer LD, Liboiron BD. Biophysical characterization of a liposomal formulation of Cytarabine and Daunorubicin. Int J Pharm. 2010;391(1\u20132):248\u201359. https:\/\/doi.org\/10.1016\/j.ijpharm.2010.02.014.","journal-title":"Int J Pharm"},{"key":"4423_CR190","doi-asserted-by":"publisher","DOI":"10.3389\/fddev.2024.1383038","author":"DG van Zyl","year":"2024","unstructured":"van Zyl DG, Mendes LP, Semper RP, Rueckert C, Baumhof P. Poly(2-methyl-2-oxazoline) as a polyethylene glycol alternative for lipid nanoparticle formulation. Front Drug Deliv. 2024. https:\/\/doi.org\/10.3389\/fddev.2024.1383038.","journal-title":"Front Drug Deliv"},{"key":"4423_CR191","doi-asserted-by":"publisher","unstructured":"Sanchez AJDS, Loughrey D, Echeverri ES, Huayamares SG, Radmand A, Paunovska K, et al. Substituting Poly(Ethylene Glycol) Lipids with Poly(2-Ethyl-2-Oxazoline) Lipids Improves Lipid Nanoparticle Repeat Dosing. Adv Healthc Mater. n\/a(n\/a):2304033. https:\/\/doi.org\/10.1002\/adhm.202304033","DOI":"10.1002\/adhm.202304033"},{"issue":"26","key":"4423_CR192","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202211420","volume":"35","author":"K Lam","year":"2023","unstructured":"Lam K, Schreiner P, Leung A, Stainton P, Reid S, Yaworski E, et al. Optimizing lipid nanoparticles for delivery in primates. Adv Mater. 2023;35(26):2211420. https:\/\/doi.org\/10.1002\/adma.202211420.","journal-title":"Adv Mater"},{"issue":"2","key":"4423_CR193","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtm.2025.101470","volume":"33","author":"D Stone","year":"2025","unstructured":"Stone D, Takeuchi R, Dulin H, Loprieno MA, Strongin DE, Sathees S, et al. Serum factors create species-specific barriers to hepatic gene transfer by lipid nanoparticles in liver-humanized mice. Mol Ther Methods Clin Dev. 2025;33(2):101470. https:\/\/doi.org\/10.1016\/j.omtm.2025.101470.","journal-title":"Mol Ther Methods Clin Dev"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-026-04423-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04423-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04423-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:23:13Z","timestamp":1781648593000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12951-026-04423-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,27]]},"references-count":193,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4423"],"URL":"https:\/\/doi.org\/10.1186\/s12951-026-04423-0","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,27]]},"assertion":[{"value":"9 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors confirm that this work is original, has not been previously published, and is not under consideration for publication elsewhere. They have all consented to submitting this manuscript to the Journal of Nanobiotechnology.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}],"article-number":"558"}}